Filana Therapeutics (SAVA.MX) Q1 2026 Earnings

Mar 12Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-17.29
-12.87
-8.45
-4.03

Details

Expected EPS
-5.31663
Actual EPS
-4.607746000000001
Surprise EPS
0.71
Surprise Percent
+13.33%

Description

⁨Filana Therapeutics⁩ (⁦SAVA.MX⁩) has reported earnings of ⁦-4.607746000000001⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts